Diagnostic and therapeutic challenges of childhood brucellosis in a nonendemic country

Pediatrics

Volumn 121, Issue 5, 2008, Pages

  Shen, Mark W ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UTMB Pediatrics Austin   (United States)

Author keywords

Brucellosis; Child; Epidemiology; Mexico; United states; Zoonoses

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; LIVER ENZYME; RIFAMPICIN; TETRACYCLINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADOLESCENT; ADULT; AGGLUTINATION TEST; ANTIBIOTIC THERAPY; ARTHRITIS; ARTICLE; BLOOD CULTURE; BLOOD SAMPLING; BRUCELLA MELITENSIS; BRUCELLOSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG TREATMENT FAILURE; ENZYME BLOOD LEVEL; FEMALE; FEVER; HEPATOSPLENOMEGALY; HUMAN; JAUNDICE; KNEE PAIN; MALE; MEDICAL RECORD REVIEW; MEXICO; MILK; OSTEOMYELITIS; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RASH; RELAPSE; RETROSPECTIVE STUDY; SACROILIITIS; SCHOOL CHILD; TERTIARY HEALTH CARE; TREATMENT DURATION; UNITED STATES; ANIMAL; HISPANIC; ISOLATION AND PURIFICATION; MICROBIOLOGY; RECURRENT DISEASE; TRAVEL;

ADOLESCENT; ANIMALS; BRUCELLA MELITENSIS; BRUCELLOSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MEXICAN AMERICANS; MEXICO; MILK; RECURRENCE; TEXAS; TRAVEL;

EID: 44449159497     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1874     Document Type: Article

References (41)

1. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6(2):91-99
2. Taylor JP, Perdue JN. The changing epidemiology of human brucellosis in Texas, 1977-1986. Am J Epidemiol. 1989;130(1): 160-165
3. Chomel BB, DeBess EE, Mangiamele DM, et al. Changing trends in the epidemiology of human brucellosis in California from 1973 to 1992: a shift toward foodborne transmission. J Infect Dis. 1994;170(5):1216-1223
4. Chang MH, Glynn MK, Groseclose SL. Endemic, notifiable bioterrorism-related diseases, United States, 1992-1999. Emerg Infect Dis. 2003;9(5):556-564
5. Fosgate GT, Carpenter TE, Chomel BB, Case JT, DeBess EE, Reilly KF. Time-space clustering of human brucellosis, California, 1973-1992. Emerg Infect Dis. 2002;8(7):672-678
6. Ragan VE. The Animal and Plant Health Inspection Service (APHIS) brucellosis eradication program in the United States. Vet Microbiol. 2002;90(1-4):11-18
7. Hopkins RS, Jajosky RA, Hall PA, et al. Summary of notifiable diseases: United States, 2003. MMWR Morb Mortal Wkly Rep. 2005;52(54):1-85
8. Luna-Martinez JE, Mejia-Teran C. Brucellosis in Mexico: current status and trends. Vet Microbiol. 2002;90(1-4):19-30
9. Kahler SC. Brucella melitensis infection discovered in cattle for first time, goats also infected. J Am Vet Med Assoc Online. March 1, 2000. Available at: www.avma.org/onlnews/javma/mar00/s030100b.asp. Accessed June 21, 2007
10. Arnow PM, Smaron M, Ormiste V. Brucellosis in a group of travelers to Spain. JAMA. 1984;251(4):505-507
11. Young EJ, Corbel MJ. Brucellosis: epidemiology and prevalence worldwide. In: Brucellosis: Clinical and Laboratory Aspects. Boca Raton, FL: CRC Press; 1989:25-40
12. Shaalan MA, Memish ZA, Mahmoud SA, et al. Brucellosis in children: clinical observations in 115 cases. Int J Infect Dis. 2002;6(3):182-186
13. al-Eissa YA, Kambal AM, al-Nasser MN, al-Habib SA, al-Fawaz IM, al-Zamil FA. Childhood brucellosis: a study of 102 cases. Pediatr Infect Dis J. 1990;9(2):74-79
14. Madkour MM. Childhood brucellosis. In: Madkour's Brucellosis. 2nd ed. Berlin, Germany: Springer; 2001:205-220
15. Young EJ. An overview of human brucellosis. Clin Infect Dis. 1995;21(2):283-289; quiz 290
16. Eren S, Bayam G, Ergonul O, et al. Cognitive and emotional changes in neurobrucellosis. J Infect. 2006;53(3):184-189
17. Young DA. Florence Nightingale's fever. BMJ. 1995;311(7021): 1697-1700
18. Geyik MF, Gur A, Nas K, et al. Musculoskeletal involvement of brucellosis in different age groups: a study of 195 cases. Swiss Med Wkly. 2002;132(7-8):98-105
19. al-Eissa YA, Kambal AM, Alrabeeah AA, Abdullah AM, al-Jurayyan NA, al-Jishi NM. Osteoarticular brucellosis in children. Ann Rheum Dis. 1990;49(11):896-900
20. Benjamin B, Annobil SH, Khan MR. Osteoarticular complications of childhood brucellosis: a study of 57 cases in Saudi Arabia. J Pediatr Orthop. 1992;12(6):801-805
21. Yagupsky P. Detection of Brucellae in blood cultures. J Clin Microbiol. 1999;37(11):3437-3442
22. Street L Jr, Grant WW, Alva JD. Brucellosis in childhood. Pediatrics. 1975;55(3):416-421
23. Baysallar M, Aydogan H, Kilic A, Kucukkaraaslan A, Senses Z, Doganci L. Evaluation of the BacT/ALERT and BACTEC 9240 automated blood culture systems for growth time of Brucella species in a Turkish tertiary hospital. Med Sci Monit. 2006;12(7): BR235-BR238
24. Spink WW. The Nature of Brucellosis. Minneapolis, MN: University of Minnesota Press; 1956
25. Karakukcu M, Patiroglu T, Ozdemir MA, Gunes T, Gumus H, Karakukcu C. Pancytopenia, a rare hematologic manifestation of brucellosis in children. J Pediatr Hematol Oncol. 2004;26(12): 803-806
26. Shalev H, Abramson O, Levy J. Hematologic manifestations of brucellosis in children. Pediatr Infect Dis J. 1994;13(6):543-545
27. Joint FAO/WHO expert committee on brucellosis. World Health Organ Tech Rep Ser. 1986;740:1-132
28. Hasanjani Roushan MR, Mohraz M, Hajiahmadi M, Ramzani A, Valayati AA. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Clin Infect Dis. 2006;42(8):1075-1080
29. Solera J, Espinosa A, Martinez-Alfaro E, et al. Treatment of human brucellosis with doxycycline and gentamicin. Antimicrob Agents Chemother. 1997;41(1):80-84
30. Solera J, Rodriguez-Zapata M, Geijo P, et al. Doxycyclinerifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Antimicrob Agents Chemother. 1995;39(9): 2061-2067
31. Colmenero JD, Fernandez-Gallardo LC, Agundez JA, Sedefio J, Benitez J, Valverde E. Possible implications of doxycyclinerifampin interaction for treatment of brucellosis. Antimicrob Agents Chemother. 1994;38(12):2798-2802
32. Lubani MM, Dudin KI, Sharda DC, et al. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J. 1989;8(2):75-78
33. Khuri-Bulos NA, Daoud AH, Azab SM. Treatment of childhood brucellosis: results of a prospective trial on 113 children. Pediatr Infect Dis J. 1993;12(5):377-381
34. Sanchez-Tamayo T, Colmenero JD, Martinez-Cortes F, et al. Failure of short-term antimicrobial therapy in childhood brucellosis. Pediatr Infect Dis J. 1997;16(3):323-324
35. El Miedany YM, El Gaafary M, Baddour M, Ahmed I. Human brucellosis: do we need to revise our therapeutic policy? J Rheumatol. 2003;30(12):2666- 2672
36. Hall WH. Modern chemotherapy for brucellosis in humans. Rev Infect Dis. 1990;12(6):1060-1099
37. Hughes ML. Mediterranean, Malta or Undulant Fever. New York, NY: McMillan and Co; 1897:150
38. Madkour MM. Treatment. In: Madkour's Brucellosis. 2nd ed. Berlin, Germany: Springer; 2001:241-261
39. Mantur BG, Akki AS, Mangalgi SS, Patil SV, Gobbur RH, Peerapur BV. Childhood brucellosis: a microbiological, epidemiological and clinical study. M Trop Pediatr. 2004;50(3):153-157
40. Sharda DC, Lubani M. A study of brucellosis in childhood. Clin Pediatr (Phila). 1986;25(10):492-495
41. Feiz J, Sabbaghian H, Miralai M. Brucellosis due to B. melitensis in children: clinical and epidemiologic observations on 95 patients studied in central Iran. Clin Pediatr (Phila). 1978;17(12): 904-907